The AGE product Nε-(carboxymethyl)lysine serum albumin is a modulator of proteoglycan expression in polarized cultured kidney epithelial cells

Diabetologia

Volumn 44, Issue 4, 2001, Pages 488-494

  Borrebaek J ^a   Prydz, K ^a   Fjeldstad, K ^a   Vuong, T T ^a   Berg, T J ^b   Holkov, C ^a   Kolset, S O ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Advanced glycation end product; CML BSA; Diabetes; Kidney; MDCK cells; Proteoglycans

Indexed keywords

ALBUMIN; GLUCOSAMINE; LYSINE DERIVATIVE; N EPSILON (CARBOXYMETHYL)LYSINE; PROTEOGLYCAN; SULFATE; SULFUR 35; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LABELING; CONTROLLED STUDY; DIABETES MELLITUS; ELECTROPHORESIS; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GEL CHROMATOGRAPHY; GLOMERULUS BASEMENT MEMBRANE; GLYCATION; ION EXCHANGE CHROMATOGRAPHY; KIDNEY EPITHELIUM; KIDNEY FUNCTION; MOLECULAR SIZE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

ANIMALS; CELL LINE; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, ION EXCHANGE; DOGS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITHELIAL CELLS; GLUCOSAMINE; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; KIDNEY; LYSINE; PROTEOGLYCANS; SERUM ALBUMIN; SULFATES; SULFUR RADIOISOTOPES; TRITIUM;

EID: 17544393387     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051647     Document Type: Article

References (29)

1. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: Relevance of glycated collagen products versus HbA1 c as markers of diabetic complications
2. Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus
3. Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy
4. Glomerular heparan sulfate alterations: Mechanisms and relevance for proteinuria
5. The glomerular basement membrane. A selective macromolecular filter
6. Identification of two strains of MDCK cells which resemble separate nephron tubule segments
7. Proteoglycans in polarized epithelial Madin-Darby canine kidney cells
8. Apical secretion of chondroitin sulphate in polarized Madin-Darby Canine Kidney (MDCK) cells
9. Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy
10. ε(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes
11. ε(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins
12. Antibodies against in vitro generated AGE: Specificity and applicability to assays for in vivo AGE
13. Formation of anhydrosugars in the chemical depolymerization of heparin
14. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus
15. Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy
16. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process
17. ε-(carboxymethyl)lysine in human tissues in diabetes and aging
18. ε-carboxymethyllysine-protein adducts, an advanced glycation endproduct
19. The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas
20. ε-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction
21. Early glomerulopathy is present in young, Type I (insulin-dependent) diabetic patients with microalbuminuria
22. A specific structural alteration in the heparan sulphate of human glomerular basement membrane in diabetes
23. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression
24. Advanced glycation end products: A Nephrologist's perspective
25. A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats
26. Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases
27. Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis
28. Expression of glomerular extracellular matrix components in human diabetic nephropathy: Decrease of heparan sulphate in the glomerular basement membrane
29. Reduced sulfation of liver heparan sulfate in experimentally diabetic rats